Amgen announces PDUFA date for XGEVA® supplemental Biologics License Application
22 August 2011 | By Amgen
The FDA will target a PDUFA action date of April 26, 2012 for the sBLA...
List view / Grid view
News
FDA Clears Abbott’s Genetic FISH Panel for Leukemia Patient Prognosis
22 August 2011 | By
Abbott has received 510k clearance from the FDA...
GSK takes minority stake in new spin out Autifony Therapeutics
22 August 2011 | By GlaxoSmithKline
GSK will receive a 25.4% minority equity stake, representing a £1,250,000 investment, in Autifony Therapeutics Limited...
Wyatt Technology’s FFF-MALS provides efficient Liposome Characterization
19 August 2011 | By The Scott Partnership
FFF technology combined with MALS & QELS enables rapid measurements of particle size, size distribution, particle count, & structure...
EMA accepts marketing authorization application for Ridaforolimus, investigational mTOR inhibitor
18 August 2011 | By
Merck to pay ARIAD $25 million milestone payment for acceptance of filing...
Pfizer announces EMA acceptance of regulatory submissions for two investigational cancer therapies
17 August 2011 | By Pfizer
EMA accepted Pfizer’s regulatory submissions for review of two investigational compounds...
FDA approval of Zelboraf(TM) (vemurafenib) establishes oncology foothold in US for Daiichi Sankyo
17 August 2011 | By Daiichi Sankyo
First-in-class treatment option soon available to treat deadly form of skin cancer...
FDA approves Zelboraf (vemurafenib)
17 August 2011 | By Roche
First and only personalized medicine shown to help people with BRAF V600E mutation-positive metastatic melanoma...
Tecan’s MCA 384 adapter plate concept provides ultimate flexibility
16 August 2011 | By kdm communications
The flexibility offered by Tecan’s MultiChannel Arm™ (MCA) 384 and Freedom EVO® liquid handling platform is vital to researchers...
FDA approve two three-month strengths of Lupron Depot-PED® (leuprolide acetate for depot suspension)
16 August 2011 | By Abbott
Two strengths for three-month administration of Lupron Depot-PED ® approved...
Bristol-Myers Squibb announces winners of “Fight HIV Your Way” contest
16 August 2011 | By Bristol-Myers Squibb Company
Winners of the 2011 REYATAZ® (atazanavir sulfate) “Fight HIV Your Way” contest announced...
Pfizer wins Viagra patent trial
15 August 2011 | By Pfizer
Pfizer Inc. has prevailed in its patent infringement action against Teva Pharmaceuticals USA, Inc. in the United States District Court for the Eastern District of VA...
GSK and Impax announce positive topline results of ASCEND-PD Phase III study of IPX066 in Advanced Parkinson’s disease
15 August 2011 | By GlaxoSmithKline
Top-line results of the ASCEND-PD Phase III clinical study...
Gilead’s investigational antiretroviral Quad regimen meets 48-week primary objective in pivotal Phase 3 Clinical Study 102
15 August 2011 | By Gilead Sciences
Phase 3 clinical trial met its primary objective...
“Drug hunter” honoured
11 August 2011 | By University of Brighton
One of the world’s most renowned “drug hunters” has been awarded an honorary Doctor of Science from the University of Brighton...
